Gene: EIF4EBP1
Official Full Name: eukaryotic translation initiation factor 4E binding protein 1provided by HGNC
Gene Summary: This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09135 | EIF4EBP1 Knockout cell line (HeLa) | Human | EIF4EBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO09136 | EIF4EBP1 Knockout cell line (HCT 116) | Human | EIF4EBP1 | 1:2~1:4 | Negative | Online Inquiry |
KO09137 | EIF4EBP1 Knockout cell line (HEK293) | Human | EIF4EBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO09138 | EIF4EBP1 Knockout cell line (A549) | Human | EIF4EBP1 | 1:3~1:4 | Negative | Online Inquiry |
EIF4EBP1 Gene Knockout Cell Lines are genetically engineered cell lines designed to facilitate the study of the eukaryotic translation initiation factor 4E-binding protein 1 (eIF4E-BP1), a crucial regulator of protein synthesis and cellular growth. By knocking out the EIF4EBP1 gene, these cell lines provide a valuable tool for examining the signaling pathways and regulatory mechanisms that eIF4E-BP1 influences, particularly in relation to cap-dependent translation, cell cycle progression, and stress responses.
The primary function of the EIF4EBP1 knockout cell lines is to enable researchers to investigate the biological consequences of eIF4E-BP1 deficiency. This is achieved through the elimination of eIF4E-BP1's ability to bind to and modulate the activity of the eIF4E translation factor, thereby allowing for uncontrolled protein translation under certain conditions. This unique mechanism of action aids in exploring how aberrant protein synthesis contributes to various diseases, including cancer, obesity, and neurological disorders.
Scientifically, EIF4EBP1 knockout cell lines have significant applications in both research and clinical settings. They are instrumental in deciphering the role of eIF4E-BP1 in cellular processes and are pivotal for identifying potential therapeutic targets in cancer treatment. By manipulating these cell lines, researchers can develop novel strategies to regulate protein synthesis and further understand tumorigenesis mechanisms.
One of the key advantages of our EIF4EBP1 knockout cell lines lies in their specificity and reliability. Compared to alternative models, these knockout lines ensure precise targeting of the EIF4EBP1 gene, minimizing off-target effects and providing consistent observations across experimental replicates. This specificity enhances data quality and reproducibility, which is crucial for advancing scientific knowledge.
Our product stands out for its potential to accelerate discoveries and innovations in translational research and drug development. By utilizing the EIF4EBP1 knockout cell lines, researchers and clinicians can bridge the gap between basic and applied sciences, paving the way for breakthroughs in understanding complex diseases.
With extensive expertise in cell line development and genetic engineering, our company is committed to providing high-quality biological products that empower scientific discovery. Our thorough validation processes and comprehensive customer support ensure that our clients have the tools they need to excel in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.